Jejunal diverticulosis: complications and management – a case series
Abstract
Abstract Jejunal diverticulosis (JD) is rare (incidence of 0.5%–6%), more common in the elderly, and often asymptomatic. However, complications like diverticulitis, perforation, obstruction and gastrointestinal bleeding pose diagnostic and management challenges. This case series describes five patients with complicated JD. Four had jejunal diverticulitis, two with free perforation requiring emergency surgery, two with chronic inflammation. The fifth patient had severe gastrointestinal bleeding undetected by conventional endoscopy requiring advanced diagnostics. Three patients with diverticulitis underwent successful segmental resection, one was managed conservatively. The patient with gastrointestinal bleeding responded to conservative management without a surgical intervention. JD can cause life threatening complications. Clinicians should suspect it in elderly patients with acute abdominal symptoms or obscure gastrointestinal bleeding. Prompt imaging and individualized management are crucial for optimizing outcomes. This report highlights the need for greater awareness of JD as a differential diagnosis in abdominal pain and gastrointestinal hemorrhage.
How strong is the evidence?
Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Challenges and opportunities with drug repurposing: finding strategies to find alternative uses of therapeutics
- Challenges in Chagas Disease Drug Development
- T Cell Specificity: A Great Challenge in Chagas Disease
- Benznidazole treatment leads to DNA damage in Trypanosoma cruzi and the persistence of rare widely dispersed non-replicative amastigotes in mice
- Rapid Molecular Detection of Terbinafine-resistant Dermatophytes
- Identifying novel drugs with new modes of action for neglected tropical fungal skin diseases (fungal skinNTDs) using an Open Source Drug discovery approach
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.